Quick Search 
Drugs of the Future
Register or sign in

Volume 30, Issue 12, December 2005, Pages 1205-1304
Anti-HIV agent, Reverse transcriptase inhibitor.
McIntyre, J.A., Castaner, J.
Drugs Fut 2005, 30(12): 1205
Summary | Full Text: HTMLPDF 
Antiepileptic drug.
Rosenberg, G., Friedman, J.E., Shapiro, I., Kozak, A.
Drugs Fut 2005, 30(12): 1212
Summary | Full Text: HTMLPDF 
Asthma therapy, Treatment of COPD, β2-Adrenoceptor agonist.
Davies, S.L., Castaner, J.
Drugs Fut 2005, 30(12): 1219
Summary | Full Text: HTMLPDF 
Oncolytic, Dual EGFR and erbB-2 inhibitor.
Boyd, B., Bozzo, J., Castaner, J., Bayes, M.
Drugs Fut 2005, 30(12): 1225
Summary | Full Text: HTMLPDF 
 New oral iron-chelating drugs for the treatment of transfusional iron overload and other diseases.
Kotonghiorghes, G.J.
Drugs Fut 2005, 30(12): 1241
Summary | Full Text: HTMLPDF 
 Phytotherapies for diabetes.
Zareba, G., Serradell, N., Castaner, R., Davies, S.L., Prous, J., Mealy, N.
Drugs Fut 2005, 30(12): 1253
Summary | Full Text: HTMLPDF 
 Sitaxsentan: update on basic science studies and clinical trials supporting selective endothelin ETA receptor antagonism in the treatment of pulmonary arterial hypertension.
Davie, N.J., Coyne, T.C., Dixon, R.
Drugs Fut 2005, 30(12): 1283
Summary | Full Text: HTMLPDF 
 Pharmacostructural Index.
Drugs Fut 2005, 30(12): 1295
Full Text: PDF 

© 2020 Clarivate Analytics. All rights reserved.
Copyright NoticeTerms of UsePrivacy StatementCookie Policy